Cancer statistics, 2013
- PMID: 23335087
- DOI: 10.3322/caac.21166
Cancer statistics, 2013
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,660,290 new cancer cases and 580,350 cancer deaths are projected to occur in the United States in 2013. During the most recent 5 years for which there are data (2005-2009), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.5% per year in women. Overall, cancer death rates have declined 20% from their peak in 1991 (215.1 per 100,000 population) to 2009 (173.1 per 100,000 population). Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate). Over the past 10 years of data (2000-2009), the largest annual declines in death rates were for chronic myeloid leukemia (8.4%), cancers of the stomach (3.1%) and colorectum (3.0%), and non-Hodgkin lymphoma (3.0%). The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of approximately 1.18 million deaths from cancer, with 152,900 of these deaths averted in 2009 alone. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket and other underserved populations.
Copyright © 2012 American Cancer Society, Inc.
Similar articles
-
Cancer statistics, 2012.CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22237781
-
Cancer statistics, 2015.CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5. CA Cancer J Clin. 2015. PMID: 25559415
-
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17. CA Cancer J Clin. 2011. PMID: 21685461
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
-
Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales.Radiol Med. 2015 Dec;120(12):1170-6. doi: 10.1007/s11547-015-0555-8. Epub 2015 May 24. Radiol Med. 2015. PMID: 26002724
-
FGFR-2 and Epithelial-Mesenchymal Transition in Endometrial Cancer.J Clin Med. 2022 Sep 15;11(18):5416. doi: 10.3390/jcm11185416. J Clin Med. 2022. PMID: 36143062 Free PMC article.
-
A cost analysis of a pancreatic cancer screening protocol in high-risk populations.Am J Surg. 2015 Sep;210(3):409-16. doi: 10.1016/j.amjsurg.2014.11.017. Epub 2015 Apr 24. Am J Surg. 2015. PMID: 26003200 Free PMC article.
-
Evolving role of neoadjuvant therapy in rectal cancer.Curr Treat Options Oncol. 2013 Sep;14(3):350-64. doi: 10.1007/s11864-013-0242-8. Curr Treat Options Oncol. 2013. PMID: 23828092
-
CT contrast enhancement correlates with pathological grade and microvessel density of pancreatic cancer tissues.Int J Clin Exp Pathol. 2015 May 1;8(5):5443-9. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191248 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous